CCNG2 and gastric cancer: In summary, this study established that cyclin G2 suppresses Wnt/β-catenin signaling in gastric cancer, acting through association with and impact Dpr1 phosphorylation to stimulate β-catenin degradation in a GSK-3β-dependent manner.